1. Home
  2. MTNB

MTNB

Matinas Biopharma Holdings Inc.

Logo Matinas Biopharma Holdings Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Founded: 2013 Country:
United States
United States
Employees: N/A City: BEDMINSTER
Market Cap: 51.0M IPO Year: N/A
Target Price: $3.00 AVG Volume (30 days): 1.6M
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.11 EPS Growth: N/A
52 Week Low/High: $0.11 - $0.89 Next Earning Date: 05-08-2024
Revenue: $1,096,000 Revenue Growth: -65.62%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: